Webinar Ticagrelor removal by CytoSorb / Budget impact analysis of CytoSorb Therapy in emergency open-heart surgery patients receiving Ticagrelor (Brilliere)
- Cardiac Surgery
Ticagrelor removal by CytoSorb in patients with acute coronary syndrome – clinical benefits and scientific results.
Priv. Doz. Dr. med. Stephan Geidel
Chief Senior Physician Cardiac Surgery – Asklepios Klinik St. Georg, Hamburg
Budget impact analysis of CytoSorb therapy in emergency open-heart surgery patients receiving Ticagrelor (Brillique).
Daniel Adam Blanco
Manager Health Economics – CytoSorbents Europe GmbH, Berlin
Share
|
Webinar Ticagrelor removal by CytoSorb / Budget impact analysis of CytoSorb Therapy in emergency open-heart surgery patients receiving Ticagrelor (Brilliere)
- April 23, 2020
- Cardiac Surgery
Share
|
Ticagrelor removal by CytoSorb in patients with acute coronary syndrome – clinical benefits and scientific results.
Priv. Doz. Dr. med. Stephan Geidel
Chief Senior Physician Cardiac Surgery – Asklepios Klinik St. Georg, Hamburg
Budget impact analysis of CytoSorb therapy in emergency open-heart surgery patients receiving Ticagrelor (Brillique).
Daniel Adam Blanco
Manager Health Economics – CytoSorbents Europe GmbH, Berlin
More Videos
